ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Construction Money In Budget Earmarked For Frederick

February 9, 1990

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013